太龙药业(600222.SH)：控股股东筹划公司股份转让事宜 股票停牌

Core Viewpoint - Tai Long Pharmaceutical (600222.SH) announced that it received a notification from its controlling shareholder, Tai Rong Chan Investment, regarding a planned share transfer that may lead to a change in the company's control [1] Group 1 - The share transfer is being planned by the controlling shareholder, which indicates potential significant changes in the company's governance structure [1] - The company's stock will be suspended from trading starting December 2, 2025, with an expected suspension period of no more than 2 trading days [1]